Learn more

WORLD TRADE IMP EXPORT WTIE AG

Overview
  • Total Patents
    109
About

WORLD TRADE IMP EXPORT WTIE AG has a total of 109 patent applications. Its first patent ever was published in 2005. It filed its patents most often in Brazil, Mexico and Argentina. Its main competitors in its focus markets pharmaceuticals are TECHNICAL SOURCING INTERNATION, JIANGXI QIANLONG PHARMACEUTICAL CO LTD and BESINS INT BELGIQUE.

Patent filings per year

Chart showing WORLD TRADE IMP EXPORT WTIE AGs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals

Focus technologies

Top inventors

# Name Total Patents
#1 Murillo Josefina Santos 58
#2 Ochoa Victor Guillermo Alvarez 51
#3 Garcia Armenta Maria Elena 49
#4 Alvarez Ochoa Victor Guillermo 47
#5 Santos Murillo Josefina 44
#6 Armenta Maria Elena Garcia 32
#7 Armenta Ma Elena Garcia 19
#8 Armenta Patricia Garcia 9
#9 Garcia Armenta Patricia 5
#10 Ochoa Victor Guillermo Álvarez 4

Latest patents

Publication Filing date Title
BRPI0813087A2 Pharmaceutical composition understanding the combination of an antimicrobian agent and a selective inhibitor of encephaline, indicated for the control and treatment of acute bacterial original diarrhea.
BRPI0814057A2 Pharmaceutical composition understanding the combination of an antidepressive agent and an ansiolytic agent for the control and treatment of depressive disorders
BRPI0717117A2 Pharmaceutical combinations for the treatment of additional hypertension diplidememia
MX2007011927A Pharmaceutical compositions combining a nonsteroidal anti-inflammatory agent and a xanthine oxidase inhibiting agent, which can be used to control and treat gout, gouty arthritis and related diseases.
MX2007011931A Pharmaceutical composition combining an antiarthritic agent and an interleukin-1 inhibiting agent, which can be used to control and treat osteoarthritis and related diseases.
MX2007011002A Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency.
MX2007011003A Pharmaceutical composition combining a non-steroidal anti-inflammatory, a centrally acting muscle relaxant and an interleukin-1 inhibitor, which can be used in the treatment of rheumatoid arthritis and related diseases.
MX2007011001A Pharmaceutical composition comprising the combination of a steroidal anti-inflammatory and a muscle relaxant for controlling and treating musculoskeletal inflammatory diseases accompanied by muscle contracture.
MX2007009121A Pharmaceutical composition combining an antimicrobial agent and a selective enkephalinase enzyme inhibitor, which can be used to control and treat acute bacterial diarrhoea.
MX2007009120A Pharmaceutical composition combining an antiandrogenic agent, a synthetic steroidal estrogenic agent and vitamin agents, which can be used to control and treat late-onset female acne.
MX2007008644A Pharmaceutical composition combining an anticonvulsant agent and a benzodiazepinic agent prescribed for the control and treatment of convulsive disorders and epileptic syndromes.
MX2007008642A Pharmaceutical composition comprising the combination of a benzisoxazolic derived agent and a reversible inhibiting agent of the cholinesterase enzyme prescribed for the control and treatment of psychotic disorders and dementias.
MX2007008324A Pharmaceutical composition comprising the combination of an anti-depressive agent and an ansiolytic agent for control and treatment of depressive disorders.
MX2007008323A Pharmaceutical composition comprising the combination of a benzisoxazolic derived agent and a benzodiazepinic agent.
MX2007008321A Pharmaceutical composition comprising the combination of a triazolobenzodiazepine and a selective serotonin reuptake inhibitor.
MX2007007282A Pharmaceutical composition combining an enzyme hmg-coa reductase inhibiting agent and a hypolipemiant agent derived from fibric acid for treating and controlling dyslipidemias.
MX2007007283A Pharmaceutical composition combining an enzyme hmg-coa reductase inhibiting agent and a gastrointestinal lipase enzyme inhibiting agent.
MX2007006334A Pharmaceutical composition comprising the combinaton of an anti-microbial agent and an antioxidant agent for the treatment of urinary infections.
MX2007006092A Pharmaceutical compositions combining a hydrogenated lipstatin derived agent and a hmg-coa reductase inhibiting agent.
MX2007006091A Pharmaceutical composition combining a non-steroidal anti-inflammatory agent and an anticonvulsant agent.